A meta-learning framework to mitigate negative transfer in transfer learning applicable to drug design.

ABSTRACT: Data sparseness is a major limiting factor for deep machine learning. In the natural sciences, data distributions are heterogeneous. For instance, in chemistry and early-phase drug discovery, compound and molecular property data are typically sparse compared to data in other fields such as particle physics or genome biology. For machine learning in low-data regimes, approaches such as transfer learning or meta-learning have been introduced. These learning strategies are conceptually related but algorithmically distinct and typically applied independently. They share the common goal of facilitating knowledge transfer between domains with related prediction tasks and varying data availability. We were interested in combining meta- and transfer learning into a coherent framework, primarily fo

SUBMITTER: Mera A 

PROVIDER: S-EPMC12511290 | biostudies-literature | 2025 Oct

REPOSITORIES: biostudies-literature